Botanix isn't sweating on FDA approval for Sofdra
Botanix has submitted the last label materials to the FDA seeking approval for Sofdra™ a prescription treatment for underarm sweating.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PEA | Ann: FY23 Trust Financials | 06/06/24 | 0 | 82 | |||
|
|||||||
PEA | Ann: FY22 Financial Statements | 15/06/23 | 0 | 205 | |||
|
|||||||
PEA | Ann: Series Notice | 05/10/21 | 0 | 287 | |||
|
|||||||
PEA | Ann: General Security Agreement | 05/10/21 | 0 | 257 | |||
|
|||||||
PEA | Ann: Master General Security Terms | 05/10/21 | 0 | 247 | |||
|
|||||||
PEA | Ann: Master Security Trust Deed | 05/10/21 | 0 | 241 | |||
|
|||||||
PEA | Ann: Master Trust Deed | 05/10/21 | 0 | 252 | |||
|
|||||||
PEA | Ann: Offering Circular | 05/10/21 | 0 | 340 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||